| Recruiting | Target-specific immunoPET Imaging of Digestive System Carcinoma NCT06715839 | RenJi Hospital | N/A |
| Completed | Enhanced Assistance During Radiotherapy for Unmet Essential Needs NCT06582849 | Washington University School of Medicine | N/A |
| Withdrawn | Data Collection of PillCamTM SB3 Capsule Endoscopy and Device-Assisted Enteroscopy Routine Care Procedures (GP NCT05450393 | Medtronic - MITG | — |
| Withdrawn | GI Organ Tracking Via Balloon Applicators NCT05471401 | Washington University School of Medicine | N/A |
| Recruiting | Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes NCT04907643 | Cedars-Sinai Medical Center | N/A |
| Completed | Nutrition in Gastrointestinal Tumors NCT04476082 | University Medicine Greifswald | — |
| Unknown | PreOPerative Imaging of NeuroEndocrine Tumors NCT03958188 | Hospices Civils de Lyon | — |
| Completed | Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA) NCT03771508 | Medtronic - MITG | — |
| Completed | Project HERO: Health Empowerment & Recovery Outcomes NCT03345563 | Rutgers, The State University of New Jersey | N/A |
| Completed | Programs To Support You During Chemotherapy NCT02489422 | Wake Forest University Health Sciences | N/A |
| Recruiting | Integrated Cancer Repository for Cancer Research NCT02012699 | University of Nebraska | — |
| Unknown | Enteroscopy for Early Diagnosis of Tumors in Celiac Disease NCT02325232 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | N/A |
| Completed | Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma NCT01273090 | Children's Oncology Group | Phase 1 |
| Completed | Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary NCT00987766 | Vanderbilt-Ingram Cancer Center | Phase 1 |
| Terminated | Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Prim NCT00903396 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Completed | Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gas NCT00836992 | Mayo Clinic | — |
| Completed | Quality of Life in Younger Leukemia and Lymphoma Survivors NCT00956475 | Case Comprehensive Cancer Center | — |
| Completed | Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer NCT00654160 | Mayo Clinic | Phase 1 |
| Completed | Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma NCT00734890 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Unknown | High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Int NCT00669812 | Cancer Research UK | Phase 2 |
| Completed | Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma NCT00569309 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma NCT00561418 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Withdrawn | Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma NCT00621036 | University of Texas Southwestern Medical Center | Phase 2 |
| Completed | KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment NCT00646139 | Roswell Park Cancer Institute | Phase 1 |
| Terminated | Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical NCT00896467 | Centre Oscar Lambret | — |
| Unknown | Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutr NCT00445497 | Clatterbridge Centre for Oncology | Phase 3 |
| Unknown | Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV P NCT00562068 | Cancer Research UK | Phase 1 |
| Completed | Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoi NCT00589563 | City of Hope Medical Center | Phase 2 |
| Completed | Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas NCT00474994 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Terminated | Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer NCT00899132 | Case Comprehensive Cancer Center | — |
| Unknown | Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastati NCT00410462 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Completed | Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed o NCT00416351 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Completed | Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal NCT00445965 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma NCT00562380 | Amgen | Phase 1 |
| Completed | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumo NCT00088868 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Completed | Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients Wi NCT00079261 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Completed | S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction NCT00049400 | SWOG Cancer Research Network | Phase 1 |
| Completed | Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma NCT00897923 | Mayo Clinic | — |
| Completed | VNP40101M in Treating Patients With Advanced or Metastatic Cancer NCT00049699 | Vion Pharmaceuticals | Phase 1 |
| Completed | Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma NCT00049712 | University of Wisconsin, Madison | Phase 1 |
| Terminated | Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract NCT00012246 | The University of Texas Medical Branch, Galveston | Phase 2 |
| Completed | CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy NCT00031941 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Completed | Pyroxamide in Treating Patients With Advanced Cancer NCT00042900 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer NCT00036790 | University of Wisconsin, Madison | Phase 1 |
| Completed | Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma NCT00006009 | Stanford University | Phase 1 |
| Completed | VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas NCT00025129 | Vion Pharmaceuticals | Phase 1 |
| Completed | ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma NCT00016172 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | BMS-247550 in Treating Patients With Advanced Cancers NCT00006221 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Tre NCT00006348 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma NCT00006357 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 1 / Phase 2 |
| Completed | Non-Ablative Allo HSCT For Hematologic Malignancies or SAA NCT00006379 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Re NCT00005639 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction NCT00004911 | Northwestern University | Phase 1 / Phase 2 |
| Completed | Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Pre NCT00005634 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction NCT00004910 | Northwestern University | Phase 1 / Phase 2 |
| Completed | Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma NCT00006039 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer NCT00004258 | Indiana University School of Medicine | Phase 1 |
| Completed | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery NCT00004895 | Northwestern University | Phase 2 |
| Completed | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer NCT00005804 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Stem Cell Transplantation in Treating Patients With Hematologic Cancer NCT00004904 | Northwestern University | Phase 1 |
| Completed | Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer NCT00004189 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma NCT00003993 | National Institute on Aging (NIA) | Phase 1 |
| Completed | Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma NCT00005590 | Cancer Research Campaign Clinical Trials Centre | Phase 3 |
| Completed | PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma NCT00004002 | NYU Langone Health | Phase 1 |
| Completed | Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer NCT00019773 | National Cancer Institute (NCI) | Phase 1 |
| Withdrawn | Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis NCT00026468 | University of Utah | Phase 2 / Phase 3 |
| Completed | Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Sof NCT00004066 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas NCT00005874 | Astex Pharmaceuticals, Inc. | Phase 2 |
| Completed | Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small NCT00489515 | Wake Forest University Health Sciences | — |
| Completed | Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy NCT00003600 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal NCT00025441 | Societe Internationale d'Oncologie Pediatrique | Phase 2 |
| Completed | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lympho NCT00019513 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Completed | Treatment for Chronic Pain in Patients With Advanced Cancer NCT00003687 | NCIC Clinical Trials Group | Phase 3 |
| Completed | Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Wh NCT00003368 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer NCT00003427 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestina NCT00019474 | Montefiore Medical Center | Phase 2 |
| Completed | Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer NCT00544193 | City of Hope Medical Center | Phase 1 |
| Terminated | Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine NCT00003522 | Burzynski Research Institute | Phase 2 |
| Completed | Flavopiridol in Treating Patients With Refractory Cancer NCT00019344 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Can NCT00005049 | NYU Langone Health | Phase 2 |
| Completed | Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor o NCT00005021 | Fox Chase Cancer Center | Phase 1 |
| Completed | Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma NCT00002759 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associate NCT00006340 | Boston Medical Center | Phase 1 |
| Completed | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas NCT00019019 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Completed | Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma NCT00003939 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |